yyb101
mAbexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2015 (NCT02499224)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Hepatocyte growth factorINHIBITOR
HGF inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- yyb101
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04368507 | Phase 1/Phase 2 (Phase 2) | Aug 9, 2019 | National OncoVenture, Yooyoung Pharmaceutical Co.,Ltd. |
| NCT02499224 | Phase 1 | Jun 1, 2015 | National OncoVenture, Yooyoung Pharmaceutical Co.,Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National OncoVenture | Academic/Hospital | 2 | 2 | 2 | 2015 |
| Yooyoung Pharmaceutical Co.,Ltd. | For profit | 2 | 0 | 2 | 2015 |
2 organizations
Page 1 / 1